Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: a systematic review and meta-analysis

被引:45
作者
Cao, Jian [1 ,3 ,4 ]
Liu, Jun [2 ]
Xu, Ran [1 ]
Zhu, Xuan [1 ]
Zhao, Xiaokun [1 ]
Qian, Bin-Zhi [3 ]
机构
[1] Cent South Univ, Dept Urol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 5, Dept Urol, Urumqi 830011, Xinjiang, Peoples R China
[3] Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland
[4] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Dept Urol, Changsha 410013, Hunan, Peoples R China
关键词
prostate cancer; tumor-associated macrophages; macrophage scavenger receptor 1; prognosis; meta-analysis; REDUCED INFILTRATION; ANDROGEN RECEPTOR; CELLS; PROGRESSION; SURVIVAL; BIOPSY; PUBLICATION; RESISTANCE; INHIBITION; EXPRESSION;
D O I
10.18632/oncotarget.18743
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies suggested that the tumour associated macrophages may be associated with prostate cancer outcome. A meta-analysis was performed to evaluate the prognostic value of tumor associated macrophages and macrophage scavenger receptor 1, marker for a subset of macrophages, by pooled hazard ratio and 95% confidence intervals from qualified studies following a systemic search. The results indicate that higher infiltration of tumor associated macrophages predicts poor overall survival (HR=1.57, 95% CI: 1.15-1.98), but not biochemical recurrence (HR=1.01, 95% CI: 0.98-1.04) or recurrence-free survival (HR=1.03, 95% CI: 0.05-2.01). In contrast, elevated level of macrophage scavenger receptor 1 was significantly associated with better recurrence-free survival (HR=3.26, 95% CI: 1.22-5.29). Thus, our analysis confirmed the prognostic value of these markers in prostate cancer outcome. We also discussed potential causes of the controversies in the literature and future research directions.
引用
收藏
页码:83261 / 83269
页数:9
相关论文
共 46 条
[1]  
[Anonymous], PLOS ONE
[2]   Role of tumor-associated macrophages in the Heximl and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma [J].
Atilgan, Alev Ok ;
Ozdemir, B. Handan ;
Akcay, Eda Yilmaz ;
Demirkan, Ozlem Ataol ;
Tekindal, M. Agah ;
Ozkardes, Hakan .
PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (02) :83-92
[3]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[4]   Scavenger receptors in homeostasis and immunity [J].
Canton, Johnathan ;
Neculai, Dante ;
Grinstein, Sergio .
NATURE REVIEWS IMMUNOLOGY, 2013, 13 (09) :621-634
[5]   Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment [J].
Chen, Po-Chun ;
Cheng, Hsu-Chen ;
Wang, John ;
Wang, Shin-Wei ;
Tai, Huai-Ching ;
Lin, Chiao-Wen ;
Tang, Chih-Hsin .
ONCOTARGET, 2014, 5 (06) :1595-1608
[6]   Making Individualized Decisions in the Midst of Uncertainties: The Case of Prostate Cancer and Biochemical Recurrence [J].
Chen, Ronald C. .
EUROPEAN UROLOGY, 2013, 64 (06) :916-918
[7]   Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study [J].
Collin, Simon M. ;
Martin, Richard M. ;
Metcalfe, Chris ;
Gunnell, David ;
CAlbertsen, Peter ;
Neal, David ;
Hamdy, Freddie ;
Stephens, Peter ;
Lane, J. Athene ;
Moore, Rollo ;
Donovan, Jenny .
LANCET ONCOLOGY, 2008, 9 (05) :445-452
[8]   Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression [J].
Comito, G. ;
Giannoni, E. ;
Segura, C. P. ;
Barcellos-de-Souza, P. ;
Raspollini, M. R. ;
Baroni, G. ;
Lanciotti, M. ;
Serni, S. ;
Chiarugi, P. .
ONCOGENE, 2014, 33 (19) :2423-2431
[9]   Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort [J].
Cuzick, J. ;
Berney, D. M. ;
Fisher, G. ;
Mesher, D. ;
Moller, H. ;
Reid, J. E. ;
Perry, M. ;
Park, J. ;
Younus, A. ;
Gutin, A. ;
Foster, C. S. ;
Scardino, P. ;
Lanchbury, J. S. ;
Stone, S. .
BRITISH JOURNAL OF CANCER, 2012, 106 (06) :1095-1099
[10]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826